These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
243 related articles for article (PubMed ID: 21696578)
1. Vpx rescues HIV-1 transduction of dendritic cells from the antiviral state established by type 1 interferon. Pertel T; Reinhard C; Luban J Retrovirology; 2011 Jun; 8():49. PubMed ID: 21696578 [TBL] [Abstract][Full Text] [Related]
2. Vpx rescue of HIV-1 from the antiviral state in mature dendritic cells is independent of the intracellular deoxynucleotide concentration. Reinhard C; Bottinelli D; Kim B; Luban J Retrovirology; 2014 Feb; 11():12. PubMed ID: 24485168 [TBL] [Abstract][Full Text] [Related]
4. Interferon block to HIV-1 transduction in macrophages despite SAMHD1 degradation and high deoxynucleoside triphosphates supply. Dragin L; Nguyen LA; Lahouassa H; Sourisce A; Kim B; Ramirez BC; Margottin-Goguet F Retrovirology; 2013 Mar; 10():30. PubMed ID: 23497353 [TBL] [Abstract][Full Text] [Related]
5. Human immunodeficiency virus type 1 modified to package Simian immunodeficiency virus Vpx efficiently infects macrophages and dendritic cells. Sunseri N; O'Brien M; Bhardwaj N; Landau NR J Virol; 2011 Jul; 85(13):6263-74. PubMed ID: 21507971 [TBL] [Abstract][Full Text] [Related]
6. The human immunodeficiency virus type 2 Vpx protein usurps the CUL4A-DDB1 DCAF1 ubiquitin ligase to overcome a postentry block in macrophage infection. Bergamaschi A; Ayinde D; David A; Le Rouzic E; Morel M; Collin G; Descamps D; Damond F; Brun-Vezinet F; Nisole S; Margottin-Goguet F; Pancino G; Transy C J Virol; 2009 May; 83(10):4854-60. PubMed ID: 19264781 [TBL] [Abstract][Full Text] [Related]
7. Characterization of simian immunodeficiency virus SIVSM/human immunodeficiency virus type 2 Vpx function in human myeloid cells. Goujon C; Arfi V; Pertel T; Luban J; Lienard J; Rigal D; Darlix JL; Cimarelli A J Virol; 2008 Dec; 82(24):12335-45. PubMed ID: 18829761 [TBL] [Abstract][Full Text] [Related]
8. Characterization of the interactions between SIVrcm Vpx and red-capped mangabey SAMHD1. Li J; Xu F; Hu S; Zhou J; Mei S; Zhao X; Cen S; Jin Q; Liang C; Guo F Biochem J; 2015 Jun; 468(2):303-13. PubMed ID: 25791246 [TBL] [Abstract][Full Text] [Related]
9. Virion-Associated Vpr Alleviates a Postintegration Block to HIV-1 Infection of Dendritic Cells. Miller CM; Akiyama H; Agosto LM; Emery A; Ettinger CR; Swanstrom RI; Henderson AJ; Gummuluru S J Virol; 2017 Jul; 91(13):. PubMed ID: 28424288 [TBL] [Abstract][Full Text] [Related]
10. Lv4 Is a Capsid-Specific Antiviral Activity in Human Blood Cells That Restricts Viruses of the SIVMAC/SIVSM/HIV-2 Lineage Prior to Integration. Pizzato M; McCauley SM; Neagu MR; Pertel T; Firrito C; Ziglio S; Dauphin A; Zufferey M; Berthoux L; Luban J PLoS Pathog; 2015 Jul; 11(7):e1005050. PubMed ID: 26181333 [TBL] [Abstract][Full Text] [Related]
11. A simple, versatile and efficient method to genetically modify human monocyte-derived dendritic cells with HIV-1-derived lentiviral vectors. Berger G; Durand S; Goujon C; Nguyen XN; Cordeil S; Darlix JL; Cimarelli A Nat Protoc; 2011 Jun; 6(6):806-16. PubMed ID: 21637200 [TBL] [Abstract][Full Text] [Related]
12. HIV-2 infects resting CD4+ T cells but not monocyte-derived dendritic cells. Chauveau L; Puigdomenech I; Ayinde D; Roesch F; Porrot F; Bruni D; Visseaux B; Descamps D; Schwartz O Retrovirology; 2015 Jan; 12():2. PubMed ID: 25582927 [TBL] [Abstract][Full Text] [Related]
13. SAMHD1 restricts HIV-1 cell-to-cell transmission and limits immune detection in monocyte-derived dendritic cells. Puigdomènech I; Casartelli N; Porrot F; Schwartz O J Virol; 2013 Mar; 87(5):2846-56. PubMed ID: 23269793 [TBL] [Abstract][Full Text] [Related]
14. Tailored HIV-1 vectors for genetic modification of primary human dendritic cells and monocytes. Durand S; Nguyen XN; Turpin J; Cordeil S; Nazaret N; Croze S; Mahieux R; Lachuer J; Legras-Lachuer C; Cimarelli A J Virol; 2013 Jan; 87(1):234-42. PubMed ID: 23077304 [TBL] [Abstract][Full Text] [Related]
15. SIVSM/HIV-2 Vpx proteins promote retroviral escape from a proteasome-dependent restriction pathway present in human dendritic cells. Goujon C; Rivière L; Jarrosson-Wuilleme L; Bernaud J; Rigal D; Darlix JL; Cimarelli A Retrovirology; 2007 Jan; 4():2. PubMed ID: 17212817 [TBL] [Abstract][Full Text] [Related]
16. A novel DCAF1-binding motif required for Vpx-mediated degradation of nuclear SAMHD1 and Vpr-induced G2 arrest. Wei W; Guo H; Han X; Liu X; Zhou X; Zhang W; Yu XF Cell Microbiol; 2012 Nov; 14(11):1745-56. PubMed ID: 22776683 [TBL] [Abstract][Full Text] [Related]
17. The poly-proline tail of SIVmac Vpx provides gain of function for resistance to a cryptic proteasome-dependent degradation pathway. Zhang N; Guo H; Yang J; Liu G; Li S; Li S; Wang D; Li R; Shu C; Xu H; Wei Z; Huang H; Zhang S; Gao P; Cen S; Markham R; Wang Y; Yu XF; Wei W Virology; 2017 Nov; 511():23-29. PubMed ID: 28803141 [TBL] [Abstract][Full Text] [Related]
18. HIV type 1 infection of plasmacytoid and myeloid dendritic cells is restricted by high levels of SAMHD1 and cannot be counteracted by Vpx. Bloch N; O'Brien M; Norton TD; Polsky SB; Bhardwaj N; Landau NR AIDS Res Hum Retroviruses; 2014 Feb; 30(2):195-203. PubMed ID: 23924154 [TBL] [Abstract][Full Text] [Related]
19. Evidence for an activation domain at the amino terminus of simian immunodeficiency virus Vpx. Gramberg T; Sunseri N; Landau NR J Virol; 2010 Feb; 84(3):1387-96. PubMed ID: 19923175 [TBL] [Abstract][Full Text] [Related]